Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03908697Not ApplicableCompleted

Quantum Natural Family Planning Pilot

Role: lead

NCT05936840Recruiting

Quantum Menstrual Health Monitoring Study

Role: lead

NCT06410170Not Yet Recruiting

Correlation of Urinary and Serum Hormone Levels in Natural Cycle Frozen Embryo Transfer Cycles

Role: collaborator

NCT05458778Unknown

Detection of Urinary Human Chorionic Gonadotropin (hCG)

Role: lead

NCT05493202Completed

Superovulation And Urinary Concentration of Estrone

Role: collaborator

All 5 trials loaded